GSK and other drugmakers on Monday asked a Delaware court for permission to appeal a ruling allowing more than 70,000 ...
A woman who claimed in a lawsuit that GSK's discontinued heartburn drug Zantac caused her breast cancer dropped her case ...
GSK said in a statement that it did not settle with the woman ... More than 72,000 lawsuits remain pending over Zantac against companies that sold the drug, which also include Pfizer and Sanofi.
GSK said in a statement that it did not settle with the woman ... More than 72,000 lawsuits remain pending over Zantac against companies that sold the drug, which also includes Pfizer and Sanofi.
Lawsuits claiming Zantac and its generic equivalents caused cancer belong in Connecticut state court, two groups of ...
GSK’s shares fell sharply following a judge's decision to allow more than 70,000 lawsuits to proceed, alleging it’s Zantac ...
The judge's decision, issued late Friday, permits expert witnesses to testify that Zantac may cause cancer. GSK, along with former Zantac manufacturers Pfizer, Sanofi (NASDAQ ... is seen as relatively ...
GSK results from a Phase 2 study that found Jemperli showed a 100% clinical complete response rate in patients with mismatch ...
GSK shares have plunged after a ruling by a Delaware judge that will force the company to face trial by jury for its Zantac ...
Along with GSK and Pfizer, Sanofi and Boehringer Ingelheim GmbH have been sued by consumers. After the federal cases were ...
Recently, Pfizer (NYSE:PFE) agreed to settle over 10,000 Zantac lawsuits. Price Action: GSK shares are up 0.09% at $45.19 at last check Friday. Disclaimer: This content was partially produced with the ...
The jury in Cook County, Illinois circuit court agreed with arguments ... was at least in part caused by her Zantac use. (Jones, 5/23) Reuters: In Sleep Apnea Device Litigation, Who's Getting The $1.1 ...